Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · IEX Real-Time Price · USD
15.77
-8.50 (-35.02%)
At close: Jul 2, 2024, 4:00 PM
16.24
+0.47 (2.98%)
After-hours: Jul 2, 2024, 7:48 PM EDT
Cartesian Therapeutics Market Cap
Cartesian Therapeutics has a market cap or net worth of $298.08 million as of July 2, 2024. Its market cap has increased by 64.69% in one year.
Market Cap
298.08M
Enterprise Value
205.12M
1-Year Change
64.69%
Ranking
Category
Stock Price
$15.77
Market Cap Chart
Since June 22, 2016, Cartesian Therapeutics's market cap has increased from $236.80M to $298.08M, an increase of 25.88%. That is a compound annual growth rate of 2.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 431.90M | 303.64% |
| Dec 29, 2023 | 107.00M | -38.11% |
| Dec 30, 2022 | 172.90M | -54.54% |
| Dec 31, 2021 | 380.30M | 16.19% |
| Dec 31, 2020 | 327.30M | 185.35% |
| Dec 31, 2019 | 114.70M | 92.13% |
| Dec 31, 2018 | 59.70M | -72.75% |
| Dec 29, 2017 | 219.10M | -29.78% |
| Dec 30, 2016 | 312.00M | 31.76% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OraSure Technologies | 301.75M |
| Foghorn Therapeutics | 300.99M |
| SOPHiA GENETICS | 300.07M |
| Agenus | 299.87M |
| Alto Neuroscience | 298.41M |
| ALX Oncology Holdings | 298.01M |
| Poseida Therapeutics | 292.81M |
| Amarin Corporation | 289.57M |